Market News Archives - Vista Partners LLC

Jerry Seinfeld’s Quiet Empire ( Now Starring Hudson Pacific Properties – $HPP )

by John F. Heerdink, Jr. 5 hours ago 93Views 0Likes

Jerry Seinfeld has built the kind of real estate-and-collector-car portfolio that makes developers, auction houses, and REIT analysts all reach for a second espresso—and Hudson Pacific Properties, Inc. (NYSE: HPP) would likely approve of the playbook. The Asset Class Behind The Laughs…

AI Trade Pauses, Oil Climbs, AMC Surges: What Drove the S&P 500 Lower Today – July 20, 2026 -( $AMC $CNK $DOCS $IMAX $NVDA Rise!)

by John F. Heerdink, Jr. 6 hours ago 1032Views 0Likes

US equities traded somewhat mixed to lower on Monday, July 20, 2026, as investors balanced rising oil prices, an AI-led factor rotation, and mounting anticipation around upcoming Big Tech earnings. The S&P 500 slipped modestly while the Dow underperformed and the Nasdaq…

The Esophagus Economy: How EP‑104GI Could Reshape EoE Treatment—and Eupraxia’s Valuation -( $EPRX $REGN $SNY )

by John F. Heerdink, Jr. 9 hours ago 43Views 0Likes

Eupraxia Pharmaceuticals, Inc. (NASDAQ: EPRX) is quietly setting up one of the more intriguing biotech inflection points on Wall Street as it marches toward Phase 2b data for EP‑104GI in eosinophilic esophagitis (EoE) this December, with investors increasingly framing the “bar” in…

AI’s New Memory Wall: Why Investors Are Piling Into the Brains Behind the Boom -( $AVGO $META $MU $NVDA $SKHY $SMWB $STX )

by John F. Heerdink, Jr. 1 day ago 99Views 0Likes

Wall Street has finally found something that can make even the most swaggering AI GPU look nervous: the memory wall. The very chips designed to feed artificial intelligence its endless diet of data are hitting physical, economic, and manufacturing limits—and the result…

AI Highs, Rate Jitters, and Lilly’s Psychedelic Shopping Spree: The Week Wall Street Needed a Therapist – July 17, 2026 -( $AMWL $HPP Rise!)

by John F. Heerdink, Jr. 3 days ago 967Views 0Likes

U.S. equities ended the week of July 17, 2026 on a cautious note, with major indexes consolidating recent gains as investors digested mixed earnings, firmer rate‑hike expectations, and evolving macro risks from weather, energy, and policy. Equity markets: tech fatigue, earnings rotation…

Telehealth 2.0: Is Amwell Quietly Becoming The Operating System Of Hybrid Care? -( $AMWL )

by John F. Heerdink, Jr. 3 days ago 154Views 0Likes

Amwell, Inc. (NYSE: AMWL, $13,02, +165.07% YTD)) is quietly scripting one of Wall Street’s more intriguing digital‑health turnarounds—an AI‑infused, platform‑first story backed by a management bench that looks more like a health‑tech all‑star team than a typical telehealth cast. Digital Care, Rewritten…

When Ransomware Milks a Billion‑Dollar Brand: Coca‑Cola, fairlife and the New Cyber Risk Premium -( $KO )

by John F. Heerdink, Jr. 4 days ago 205Views 0Likes

Wall Street just got a reminder that in 2026, “moat” now means firewalls, backups, and incident response plans as much as pricing power and brand equity. In a week where dairy tanks went quiet and industrial control systems hummed nervously, the investing…

Disinflation Wins, Tech Whimpers: A Soft Landing With Hard Questions for Wall Street – July 16, 2026 -( $HPP $INTG $VIX $YSG Rise!)

by John F. Heerdink, Jr. 4 days ago 862Views 0Likes

U.S. markets closed broadly lower on Thursday, July 16, 2026, with a decisive risk‑off tone as investors rotated out of high‑beta growth and precious metals while volatility climbed.Market close: indices and risk sentimentThe S&P 500 (^GSPC) finished at 7,533.77, down 38.63 points…

Telehealth, Cryoplants, & Cash Flows: What PsiQuantum and Amwell May Mean for Long‑Horizon Investors -( $AMWL $BLK $NVDA )

by John F. Heerdink, Jr. 4 days ago 236Views 0Likes

Amid the AI boom, a quieter revolution is unfolding at the intersection of photons, silicon, and stethoscopes—and investors are starting to lean in. From Qubits to Check‑Ups: Two Infrastructure Bets Hiding in Plain Sight If Silicon Valley once ran on sand and…

Wall Street On A Good Trip: Lilly, CareDx, And Eupraxia Rewrite The Biotech Script -( $ATAI $CDNA $EPRX $LLY )

by John F. Heerdink, Jr. 4 days ago 224Views 0Likes

Biotech’s latest plot twist has Wall Street grinning: a Big Pharma icon betting billions on psychedelics, a transplant diagnostics player finally getting its Medicare script approved, and a quietly ambitious drug-delivery innovator upgrading its cast of characters for the next act. Lilly’s…

Market News

Your Guide To Staying Informed In The Markets